BEAM
Price
$23.30
Change
-$2.24 (-8.77%)
Updated
Jan 14 closing price
Capitalization
1.93B
48 days until earnings call
INCY
Price
$71.98
Change
-$0.39 (-0.54%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
13.86B
30 days until earnings call
Ad is loading...

BEAM vs INCY

Header iconBEAM vs INCY Comparison
Open Charts BEAM vs INCYBanner chart's image
Beam Therapeutics
Price$23.30
Change-$2.24 (-8.77%)
Volume$2.4M
Capitalization1.93B
Incyte
Price$71.98
Change-$0.39 (-0.54%)
Volume$28.57K
Capitalization13.86B
BEAM vs INCY Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. INCY commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and INCY is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 15, 2025
Stock price -- (BEAM: $23.30 vs. INCY: $71.93)
Brand notoriety: BEAM: Not notable vs. INCY: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 198% vs. INCY: 77%
Market capitalization -- BEAM: $1.93B vs. INCY: $13.86B
BEAM [@Biotechnology] is valued at $1.93B. INCY’s [@Biotechnology] market capitalization is $13.86B. The market cap for tickers in the [@Biotechnology] industry ranges from $374.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileINCY’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • INCY’s FA Score: 1 green, 4 red.
According to our system of comparison, INCY is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while INCY’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 3 bearish.
  • INCY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than INCY.

Price Growth

BEAM (@Biotechnology) experienced а -13.96% price change this week, while INCY (@Biotechnology) price change was -1.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.85%. For the same industry, the average monthly price growth was -2.06%, and the average quarterly price growth was -3.70%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

INCY is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Biotechnology (-6.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INCY($13.9B) has a higher market cap than BEAM($1.93B). INCY YTD gains are higher at: 4.778 vs. BEAM (-6.048). INCY has higher annual earnings (EBITDA): 365M vs. BEAM (-160.83M). INCY has more cash in the bank: 1.78B vs. BEAM (926M). INCY has less debt than BEAM: INCY (36.5M) vs BEAM (162M). INCY has higher revenues than BEAM: INCY (4.08B) vs BEAM (350M).
BEAMINCYBEAM / INCY
Capitalization1.93B13.9B14%
EBITDA-160.83M365M-44%
Gain YTD-6.0484.778-127%
P/E RatioN/A799.22-
Revenue350M4.08B9%
Total Cash926M1.78B52%
Total Debt162M36.5M444%
FUNDAMENTALS RATINGS
INCY: Fundamental Ratings
INCY
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMINCY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 7 days ago
82%
Bearish Trend 7 days ago
64%
Momentum
ODDS (%)
Bearish Trend 7 days ago
89%
Bullish Trend 7 days ago
65%
MACD
ODDS (%)
Bearish Trend 7 days ago
86%
Bullish Trend 7 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
83%
Bearish Trend 7 days ago
63%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 8 days ago
61%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 16 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
74%
Bearish Trend 7 days ago
60%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDSKX24.310.27
+1.12%
iShares Russell 2000 Small-Cap Idx Inv A
GLNIX22.610.14
+0.62%
MFS Global New Discovery I
DFIEX15.290.09
+0.59%
DFA International Core Equity I
PEQIX24.15N/A
N/A
Pioneer Equity Income A
MAAKX22.90N/A
N/A
MoA All America Fund